Protein detail

CANB1

Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1)

Entry name
CANB1
UniProt ID
EVMP confidence score
0.40
Supporting publications (n)
1
Transmembrane count
Protein classification
FDA approved drug targetsPredicted intracellular proteins
Basic Information
Protein Names
Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1)
Protein Class (2)
FDA approved drug targetsPredicted intracellular proteins
Protein Function (2)
  • FDA approved drug targets:Small molecule drugs
  • Predicted intracellular proteins
Entrez Gene Symbol
Gene Synonym (3)
CALNB1CNBCNB1
Gene Description
Protein phosphatase 3 regulatory subunit B, alpha
Chromosome
2
Position
68178857-68256237
Supporting publications (n)
1
EVMP confidence score
0.40
Fluorescence & Localization
Cell SpecificB-cellsSingle-Nuclei Brain Specificleukocyte
Function & Pathway
Protein Function (2)
  • FDA approved drug targets:Small molecule drugs
  • Predicted intracellular proteins
Mediation Categories (5)
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation
Relations & Evidence31

Ligand-Receptor Signaling (6)

6 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
intracellularintracellularComPPI
intracellularintracellularGO_Intercell
intracellularintracellularUniProt_location
intracellularintracellularOmniPath
plasma_membraneplasma_membraneUniProt_location
plasma_membraneplasma_membraneOmniPath

Protein Complex Composition (24)

24 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
CABP1CABP2CABP5NMT1PPP3R1P30419P63098Q9NP86Q9NPB3Q9NZU71:1:1:1:1NetworkBlastCompleatCompleat:HC6082
PPP3CCPPP3R1P48454P630980:0KEGG-MEDICUS
PPIAPPP3CAPPP3R1P62937P63098Q082092:2:2PDBPDB:1mf8PDB:1m63
FKBP1APPP3R1P62942P630981:1PDBPDB:7u0t
Page 3 of 3Previous

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
PRotein Organic Solvent Precipitation;Differential UltracentrifugationMass spectrometry132384937
Sequence, Structure & Domains

Sequences

Length
170
Mass
19,300
Sequence
MGNEASYPLEMCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNPLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLDIHKKMVVDV

3D Structural Models

Helix
9..11; 17..30; 40..44; 47..49; 55..62; 72..80; 88..99; 109..120; 121..123; 126..140; 150..157; 158..160; 162..165
Beta Strand
12..14; 35..38; 67..71; 81..85; 104..107; 144..149
3D Structure
Electron microscopy (4); X-ray crystallography (14)

Domain & Motif Annotations

Domain (FT)
18..46; EF-hand 1; 50..85; EF-hand 2; 87..122; EF-hand 3; 128..163; EF-hand 4
Region
131..136; Calcineurin A binding
Protein Families
Calcineurin regulatory subunit family
Sequence Similarities
Belongs to the calcineurin regulatory subunit family.
Clinical Relevance
Disease Involvement
FDA approved drug targets
Drug Targets
FDA approved drug targets
Antibody (2)
Interaction Protein (3)
ENSG00000120910ENSG00000138814ENSG00000159200
Interaction Count
3
Interaction Dataset
intact_biogrid
Supporting Publications1
PMIDTitleRelated sentences
36114323Blood plasma derived extracellular vesicles (BEVs): particle purification liquid chromatography (PPLC) and proteomic analysis reveals BEVs as a potential minimally invasive tool for predicting response to breast cancer treatment.No related sentences available